Playing the Long Game, Partnerships Required For Emerging Infectious Diseases
Executive Summary
Bringing drugs and vaccines for emerging infectious diseases to the marketplace requires playing the long game and collaborations if efforts are going to be successful.
You may also be interested in...
Flu Hunters: House Committee Searches For Pandemic Plan
Update to 2005 outline of US response to pandemic influenza was due at the end of 2016, but has yet to be released.
Moderna's Valera Takes mRNA Approach To Combat Zika
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
NIH's Zika Vaccine Faces Funding Challenge After Skipping Industry Partnership
Agency wanted to move fast, but is now scrambling to pay for Phases I and II trials.